enVVeno Medical/$NVNO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About enVVeno Medical
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Ticker
$NVNO
Sector
Primary listing
Employees
33
Headquarters
Website
enVVeno Medical Metrics
BasicAdvanced
$7.2m
-
-$30.99
1.08
-
Price and volume
Market cap
$7.2m
Beta
1.08
52-week high
$13.44
52-week low
$8.67
Average daily volume
9.1k
Financial strength
Current ratio
11.894
Quick ratio
11.633
Long term debt to equity
0.872
Total debt to equity
2.539
Profitability
EBITDA (TTM)
-19.88
Management effectiveness
Return on assets (TTM)
-37.51%
Return on equity (TTM)
-60.65%
Valuation
Price to book
0.3
Price to tangible book (TTM)
0.3
Price to free cash flow (TTM)
-0.445
Free cash flow yield (TTM)
-224.94%
Free cash flow per share (TTM)
-24.361
Growth
Earnings per share change (TTM)
-24.37%
3-year earnings per share growth (CAGR)
-31.18%
enVVeno Medical News
AllArticlesVideos
enVVeno Medical to Present in the Webull Corporate Connect Webinar Series
Accesswire·2 weeks ago
enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
Accesswire·1 month ago
enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment
Accesswire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs